We are also actively involved in the development of cell and gene therapies, recognizing the unique challenges they present to traditional clinical trial models. With an unwavering commitment to innovation, we are exploring new frontiers in cancer treatment, harnessing the power of living therapies to provide novel and life-changing solutions.
Geistek Pharmaceuticals conducts clinical studies across a wide range of solid and hematological tumors, including breast, lung, gastric, hepatocellular carcinoma (HCC), prostate, multiple myeloma, acute myeloid leukemia (AML), lymphoma, and leukemia. Through our comprehensive research efforts, we are striving to transform the landscape of oncology and improve outcomes for patients worldwide.